WisdomTree BioRevolution Fund Rating $19.66 -0.35 (-1.75%) As of 07/24/2026 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsBuy This Stock WisdomTree BioRevolution Fund Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.WDNA Aggregate RatingModerate Buy 2.66Holdings in WDNA have an aggregate rating of Moderate Buy based on 425 analyst ratings issued in the past year covering 24 companies (55.7% of the portfolio).WDNA Aggregate Price Target$19.66High Prediction$19.66Average Prediction$19.66Low Prediction$19.66Holdings in WDNA have an aggregate price target of $19.66 and a range of $19.66 to $19.66 covering 24 companies (55.7% of the portfolio).WDNA Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy19 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by WisdomTree BioRevolution Fund Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 24 WDNA Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.61%TWSTTwist Bioscience$90.27-2.3%1.7134 of 5 stars2.70$90.30 0.0%10Positive News4.23%LLYEli Lilly and Company$1,196.18+0.9%4.0617 of 5 stars2.87$1,283.64 7.3%31Trending News3.55%MRNAModerna$54.07-5.2%1.5981 of 5 stars1.82$40.00 -26.0%17Upcoming EarningsAnalyst Forecast3.18%JNJJohnson & Johnson$263.43+1.6%4.2871 of 5 stars2.80$265.30 0.7%25Trending NewsAnalyst Upgrade2.52%UTHRUnited Therapeutics$528.47-0.2%4.6935 of 5 stars2.85$648.33 22.7%13News CoveragePositive NewsAnalyst Forecast2.46%IMNMImmunome$22.21+0.9%3.2676 of 5 stars2.86$33.17 49.3%14News CoverageAnalyst Forecast2.38%NTRANatera$261.99-1.0%3.2929 of 5 stars2.82$267.83 2.2%22Positive News2.38%TXG10x Genomics$46.27-3.7%1.6217 of 5 stars2.20$32.08 -30.7%152.36%DARDarling Ingredients$62.42-1.5%3.4235 of 5 stars2.77$67.82 8.6%13News CoveragePositive NewsUpcoming EarningsAnalyst Downgrade2.18%CTVACorteva$89.23+0.5%3.3547 of 5 stars2.68$90.19 1.1%22Trending NewsUpcoming EarningsDividend AnnouncementAnalyst Forecast2.10%GPCRStructure Therapeutics$49.12-3.3%2.2907 of 5 stars2.89$110.55 125.1%18News CoveragePositive News2.00%STOKStoke Therapeutics$29.30-1.2%2.3201 of 5 stars2.73$43.00 46.8%11News Coverage1.90%TEMTempus AI$42.69-7.2%3.607 of 5 stars2.44$68.92 61.5%16Upcoming EarningsAnalyst Forecast1.82%BGBunge Global$121.55-0.6%4.12 of 5 stars2.73$132.67 9.1%11News CoveragePositive NewsUpcoming Earnings1.82%TMOThermo Fisher Scientific$567.34-0.9%4.4836 of 5 stars2.79$613.05 8.1%24Trending NewsEarnings ReportAnalyst Forecast1.80%ROIVRoivant Sciences$35.01-0.3%1.6514 of 5 stars2.75$33.59 -4.1%12News CoveragePositive News1.80%KRYSKrystal Biotech$335.19+2.3%3.5284 of 5 stars2.83$360.67 7.6%12News CoveragePositive News1.79%RVMDRevolution Medicines$189.23+0.3%1.8178 of 5 stars2.95$144.67 -23.5%22News CoveragePositive NewsAnalyst Forecast1.67%AMGNAmgen$376.04+1.2%4.0401 of 5 stars2.43$356.62 -5.2%30Positive News1.66%BEAMBeam Therapeutics$25.10-3.1%2.539 of 5 stars2.64$46.85 86.6%14News CoveragePositive News1.65%ARWRArrowhead Pharmaceuticals$85.60-1.4%1.8827 of 5 stars2.71$93.83 9.6%14News CoverageAnalyst Forecast1.64%GILDGilead Sciences$129.31-1.2%4.9207 of 5 stars2.86$158.33 22.4%29News CoveragePositive NewsAnalyst Downgrade1.62%AGIOAgios Pharmaceuticals$36.36+0.2%2.0773 of 5 stars2.45$42.78 17.7%11Trending NewsUpcoming EarningsAnalyst ForecastAnalyst Revision1.62%CRSPCRISPR Therapeutics$46.54-2.1%3.5847 of 5 stars2.58$67.78 45.6%19News CoverageAnalyst Forecast This page (BATS:WDNA) was last updated on 7/26/2026 by MarketBeat.com Staff. From Our PartnersThe REAL Reason Trump is Invading IranFor a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Be...Banyan Hill Publishing | SponsoredUniversal basic income is not impossible. It exist (kind of)Robert Kiyosaki, author of Rich Dad Poor Dad, is highlighting an income strategy he calls the Patriot Income P...Freedom Financial | SponsoredOxford Club Analyst’s Urgent AI WarningAlexander Green, Chief Investment Strategist at The Oxford Club, is sharing a private presentation with a warn...The Oxford Club | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredThe 90%-off options that empty accountsA call that cost $3.00 last month now trades for $0.30 - a 90% discount that looks tempting. It's not a bar...Profits Run | SponsoredHave you seen Elon’s new “supercurrency”? (It affects you)Elon Musk just became the world's first trillionaire following the biggest IPO in history, giving him access t...StocksToTrade | SponsoredThis tiny piece of glass could be bigger than GPUsJensen Huang says AI can't scale without it. Google Ventures calls it the future of AI compute. Sequoia Capita...Brownstone Research | SponsoredThe trade I’ve been waiting for since 2011Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding WisdomTree BioRevolution Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share WisdomTree BioRevolution Fund With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
